Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study

por Mehta, Rashmi, Kelleher, Dennis, Preece, Andrew, Hughes, Stephen, Crater, Glenn
Publicado 2013

Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

por Church, Alison, Beerahee, Misba, Brooks, Jean, Mehta, Rashmi, Shah, Palvi
Publicado 2014

A technique to prevent overfilling of viewing chamber of intravenous infusion kit

por Kakani, Lovelesh, Sharma, Surinder M, Mehta, Rashmi C, Singh, Gurpreet
Publicado 2014

Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized study

por Mehta, Rashmi, Hardes, Kelly, Brealey, Noushin, Tombs, Lee, Preece, Andrew, Kelleher, Dennis
Publicado 2014

Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers

por Brealey, Noushin, Gupta, Ashutosh, Renaux, Jessica, Mehta, Rashmi, Allen, Ann, Henderson, Alex
Publicado 2015

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

por Mehta, Rashmi, Farrell, Colm, Hayes, Siobhán, Birk, Ruby, Okour, Malek, Lipson, David A.
Publicado 2019

A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with as...

por Bareille, Philippe, Tomkins, Susan, Imber, Varsha, Tayob, Mohammed, Dunn, Karen, Mehta, Rashmi, Khindri, Sanjeev
Publicado 2020

The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet

por Mehta, Rashmi, Piscitelli, Joseph, Wolstenholme, Allen, Fu, Caifeng, Crauwels, Herta, Wynne, Brian, Adkison, Kimberly
Publicado 2020

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD...

por Beier, Jutta, van Noord, Jan, Deans, Amanda, Brooks, Jean, Maden, Claire, Baggen, Suus, Mehta, Rashmi, Cahn, Anthony
Publicado 2012

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium/Vilanterol via a Single Inhaler in Patients with COPD

por Mehta, Rashmi, Pefani, Eleni, Beerahee, Misba, Brealey, Noushin, Barnacle, Helen, Birk, Ruby, Zhu, Chang‐Qing, Lipson, David A.
Publicado 2018

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Umeclidinium and Vilanterol Alone and in Combination: A Randomized Crossover Trial

por Kelleher, Dennis L., Mehta, Rashmi S., Jean-Francois, Bernadette M., Preece, Andrew F., Blowers, James, Crater, Glenn D., Thomas, Paul
Publicado 2012

Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial

por Hu, Chaoying, Jia, Jingying, Dong, Kelly, Luo, Linda, Wu, Kai, Mehta, Rashmi, Peng, Jack, Ren, Yan, Gross, Annette, Yu, Hui
Publicado 2015

Bioequivalence of a Fixed-Dose Combination Tablet of the Complete Two-Drug Regimen of Dolutegravir and Rilpivirine for Treatment of HIV-1 Infection

por Mehta, Rashmi, Wolstenholme, Allen, Di Lullo, Kristin, Fu, Caifeng, Joshi, Shashidhar, Crauwels, Herta, Givens, Naomi, Vanveggel, Simon, Wynne, Brian, Adkison, Kimberly
Publicado 2018